These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3762167)

  • 1. Chemotherapy in invasive thymomas: five case reports.
    Donovan PJ; Foley JF
    J Surg Oncol; 1986 Sep; 33(1):14-7. PubMed ID: 3762167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of malignant thymoma. Case report and review of the literature.
    Hu E; Levine J
    Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
    Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
    Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remission of invasive thymoma due to chemotherapy. Two patients treated with cyclophosphamide, doxorubicin, and vincristine.
    Loehrer PJ; Bonomi P; Goldman S; Reddy S; Faber LP; Jensik R; Dainauskas JR
    Chest; 1985 Mar; 87(3):377-80. PubMed ID: 3971764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide.
    Lara PN; Bonomi PD; Faber LP
    Chest; 1996 Oct; 110(4):1115-7. PubMed ID: 8874280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of thymoma].
    Monden Y; Uyama T; Kimura S; Takahashi K
    Gan To Kagaku Ryoho; 1990 Oct; 17(10):2019-24. PubMed ID: 2221924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy with cyclophosphamide, adriamycin, and vincristine in malignant thymoma and myasthenia gravis.
    Kosmidis PA; Iliopoulos E; Pentea S
    Cancer; 1988 May; 61(9):1736-40. PubMed ID: 3355974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
    Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
    Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Successful chemotherapy of a metastatic malignant thymoma].
    Göldel N; Frederik A; Böning L; Wilmanns W
    Dtsch Med Wochenschr; 1987 Sep; 112(37):1418-21. PubMed ID: 3622287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Invasive thymoma with pulmonary metastasis. Complete remission 5 years after surgery and chemotherapy using the CHOP-BLEO protocol].
    Wurtz A; Ramon P; Chambon JP; Wallaert B; Gosselin B
    Rev Mal Respir; 1988; 5(6):651-4. PubMed ID: 2464185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of combination cisplatinum, adriamycin and cyclophosphamide in malignant thymoma.
    Shiu W; Teo P; Wong K
    Br J Clin Pract; 1990 Nov; 44(11):519-20. PubMed ID: 2282317
    [No Abstract]   [Full Text] [Related]  

  • 12. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
    Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients.
    Berruti A; Borasio P; Roncari A; Gorzegno G; Mossetti C; Dogliotti L
    Ann Oncol; 1993 May; 4(5):429-31. PubMed ID: 8353078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective response to epirubicin and lonidamine. A case of advanced thymoma previously treated with the ADOC scheme and unresponsive to paclitaxel plus cyclophosphamide.
    Berruti A; Tampellini M; Gorzegno G; Dogliotti L
    Chest; 1997 May; 111(5):1473-4. PubMed ID: 9149629
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of invasive thymoma made resectable by preoperative chemotherapy].
    Tanaka K; Murota Y; Ando T; Asano K; Yamaguchi T; Wada G
    Kyobu Geka; 1996 Sep; 49(10):868-71. PubMed ID: 8828336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen.
    Weissferdt A; Moran CA
    Lung; 2013 Aug; 191(4):379-83. PubMed ID: 23652348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for malignant thymoma.
    Daugaard G; Hansen HH; Rørth M
    Ann Intern Med; 1983 Aug; 99(2):189-90. PubMed ID: 6881774
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of non-resectable thymoma which responded to the administration of adriamycin, vindesine and 5-FU].
    Sagara N; Kurooka K; Mori K; Kayama H; Haeno Y; Hara S; Yasutomi M
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3532-4. PubMed ID: 3789761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of metastatic breast cancer].
    Yahalom J; Biran S; Sulkes A
    Harefuah; 1986 Jul; 111(1-2):8-11. PubMed ID: 2430868
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy with a five-drug regimen for invasive thymoma.
    Bjerrum OW; Kiss K; Daugaard G
    Acta Oncol; 1996; 35(1):71-3. PubMed ID: 8619943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.